Explore Our Network
Explore MTEC's network of innovators, investors, and research organizations—along with patents and funding opportunities—advancing medical technologies for military and civilian health.
Showing 2 Patents
Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain
16-01-2018 • US-9867830-B2
WAINER, IRVING W. • MOADDEL, RUIN • BERNIER, MICHEL • ZARATE, CARLOS A. • TORJMAN, MARC C. • GOLDBERG, MICHAEL E. • TANGA, MARY J.
SRI International Inc • Cooper Health System Inc • Office of Technology Transfer
Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain
16-05-2017 • US-9650352-B2
WAINER, IRVING W. • MOADDEL, RUIN • BERNIER, MICHEL • ZARATE, CARLOS A. • TORJMAN, MARC C. • GOLDBERG, MICHAEL E. • TANGA, MARY J.
SRI International Inc • Cooper Health System Inc • US Department of Health and Human Services